PRE (prenetics.com) נפח מכירות חזוי

Prenetics Global (PRE) combines a startup R&D culture with the defensive qualities of a macro-independent sector. The company's sales expectations confirm this potential, with the current mark standing at 0.14. Business stability is ensured through diversification via home diagnostics and genetic tests, creating sustainable demand from both the corporate segment and private individuals.

Future sales volume represents the projected aggregate revenue from core operations based on current operational targets. The trend in the organization's planned trade revenue reflects the market consensus and is sensitive to growth expectations, while the leadership of Prenetics Global (PRE) in Asian genetic diagnostics and the release of unique oncology tests ensure the stability of this metric, protecting revenue from competitors' pricing pressure.